The Effect of Sample Glucose Content on PNGase F-Mediated N-Glycan Release Analyzed by Capillary Electrophoresis

Protein therapeutics have recently gained high importance in general health care along with applied clinical research. Therefore, it is important to understand the structure–function relationship of these new generation drugs. Asparagine-bound carbohydrates represent an important critical quality attribute of therapeutic glycoproteins, reportedly impacting the efficacy, immunogenicity, clearance rate, stability, solubility, pharmacokinetics and mode of action of the product. In most instances, these linked N-glycans are analyzed in their unconjugated form after endoglycosidase-mediated release, e.g., PNGase F-mediated liberation. In this paper, first, N-glycan release kinetics were evaluated using our previously reported in-house produced 6His-PNGase F enzyme. The resulting deglycosylation products were quantified by sodium dodecyl sulfate capillary gel electrophoresis to determine the optimal digestion time. Next, the effect of sample glucose content was investigated as a potential endoglycosidase activity modifier. A comparative Michaelis-Menten kinetics study was performed between the 6His-PNGase F and a frequently employed commercial PNGase F product with and without the presence of glucose in the digestion reaction mixture. It was found that 1 mg/mL glucose in the sample activated the 6His-PNGase F enzyme, while did not affect the release efficiency of the commercial PNGase F. Capillary isoelectric focusing revealed subtle charge heterogeneity differences between the two endoglycosidases, manifested by the lack of extra acidic charge variants in the cIEF trace of the 6His-PNGase F enzyme, which might have possibly influenced the glucose-mediated enzyme activity differences.

[1]  H. Jankovics,et al.  Enhanced Recombinant Protein Production of Soluble, Highly Active and Immobilizable PNGase F , 2022, Molecular Biotechnology.

[2]  A. Guttman,et al.  Multilevel capillary gel electrophoresis characterization of new antibody modalities. , 2021, Analytica chimica acta.

[3]  E. van Tricht,et al.  Four‐step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis , 2020, Electrophoresis.

[4]  R. Deshaies Multispecific drugs herald a new era of biopharmaceutical innovation , 2020, Nature.

[5]  Jianwei Zhu,et al.  Antibody glycosylation: impact on antibody drug characteristics and quality control , 2020, Applied Microbiology and Biotechnology.

[6]  G. Járvás,et al.  Comparative analysis of the human serum N-glycome in lung cancer, COPD and their comorbidity using capillary electrophoresis. , 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  A. Racher,et al.  Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production , 2019, Metabolic engineering.

[8]  M. Kinoshita,et al.  A fast and convenient solid phase preparation method for releasing N-glycans from glycoproteins using trypsin- and peptide-N-glycosidase F (PNGase F)-impregnated polyacrylamide gels fabricated in a pipette tip. , 2019, Journal of pharmaceutical and biomedical analysis.

[9]  M. Szigeti,et al.  Sample Preparation Scale-Up for Deep N-glycomic Analysis of Human Serum by Capillary Electrophoresis and CE-ESI-MS* , 2019, Molecular & Cellular Proteomics.

[10]  Mercedes Bonfill,et al.  Biotechnological Production of Pharmaceuticals and Biopharmaceuticals in Plant Cell and Organ Cultures. , 2018, Current medicinal chemistry.

[11]  U. Walker,et al.  Pharmacological treatment options for cryopyrin-associated periodic syndromes , 2017, Expert review of clinical pharmacology.

[12]  G. Járvás,et al.  Enzymatic removal of N‐glycans by PNGase F coated magnetic microparticles , 2016, Electrophoresis.

[13]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[14]  R. Brodsky,et al.  Paroxysmal nocturnal hemoglobinuria. , 2014, Blood.

[15]  Pauline M Rudd,et al.  Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.

[16]  Jianwei Zhu,et al.  Mammalian cell protein expression for biopharmaceutical production. , 2012, Biotechnology advances.

[17]  P. Tak,et al.  Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis , 2010, Science Translational Medicine.

[18]  B. Murtaza,et al.  Paroxysmal nocturnal hemoglobinuria. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[19]  N. Khachanova,et al.  [Highly active multiple sclerosis: options for monoclonal antibody therapy]. , 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[20]  J. Lorsch Practical steady-state enzyme kinetics. , 2014, Methods in enzymology.